Cite

HARVARD Citation

    Hanania, N. et al. (2015). Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies. Thorax. 70 (8), pp. 748-756. [Online]. 
  
Back to record